Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thromboprophylaxis in Advanced Germ Cell Tumors
NCT05874063Phase 3Recruiting
- Sponsor
- Gustave Roussy
- Start
- Oct 2023
- Primary completion
- Feb 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of low molecular weight heparin calcium in venous thromboembolism (VTE), sponsored by Gustave Roussy. Started Oct 2023; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05874063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874063.